CONMED Corporation (CNMD) Cash Flow Statement

The 2025Q3 ratio of 18.78 reflects $2.9M of net income against $53.7M of operating cash flow, a gap that suggests the quarter's cash generation was driven by working capital release and non-cash charges rather than underlying earnings power. Conversion in 2024Q2 and 2024Q3 sat closer to 1.0 to 1.4, which appears more representative of the business, so the recent spikes warrant further investigation before being treated as durable. Investors should monitor whether the trailing-year average stabilizes near earnings or continues to diverge.

The 2026Q3 rebound to $46.7M of free cash flow is encouraging, but it follows an unusually weak 2026Q1 and does not yet establish a clear upward trend across the ten-quarter window. Capital expenditure has remained contained at roughly 0.8% to 1.7% of revenue, so the margin path is driven primarily by operating cash swings rather than investment intensity. The trajectory suggests cash generation is recovering but has not demonstrated the consistency that would support a steady-state margin assumption.

The magnitude of these swings relative to net income indicates that receivables, inventory, and payables timing is the dominant source of quarterly cash variability at CNMD. A large inflow following a large outflow may reflect collection timing rather than a structural improvement in working capital efficiency, which would require further evidence. Investors should monitor whether working capital normalizes over a full annual cycle before attributing the recent operating cash strength to sustainable performance.

The transition from a consistent dividend to episodic buybacks suggests management has reallocated discretionary cash toward share repurchases, though the reported data alone does not establish the rationale. The 2026Q1 buyback of $37.0M was large relative to that quarter's $10.6M of free cash flow, which may indicate funding from balance sheet resources or working capital release rather than current-period generation. This pattern warrants further investigation into how repurchases are being sustained against weak quarterly free cash flow.